Despite Egypt being certified as malaria-free, the parasite is developing resistance to treatments, potentially costing Africa $127 billion in lost GDP by 2030 and 600,000 lives annually. The emergence of resistance to artemisinin-based therapies poses a significant threat, with key donors calling for urgent action to make alternative treatments more accessible and affordable. Malaria continues to strain African health systems and hinder economic development, highlighting the pressing need for increased funding and research to combat this evolving threat.
Full Article
Death toll hits more than 200, officials say
The death toll from devastating floods in Mokwa, Nigeria, has exceeded 200, with 500 individuals still missing as rescue efforts have ceased. The floods, described as the worst in 60 years, devastated local communities, causing significant loss of life and property, with residents recounting harrowing experiences of losing family members and livelihoods. In response, authorities are beginning to recover buried bodies to prevent disease, while the National Emergency Management Agency is providing relief packages to...
Read more